[1]梁增文, 张国, 王天才.大鼠肝纤维化中细胞外信号调节激酶的作用[J].世界华人消化杂志, 2003, 11 (6) ∶730-732.
|
[2]张晓岚, 宋梅, 白云, 等.细胞外信号调节激酶1与肝星状细胞增殖关系的体内实验研究[J].胃肠病学和肝病学杂志, 2003, 12 (5) ∶440-443.
|
[3]Feng DY, Zheng H, Tan Y, et al.Effect of phosphorylation ofMAPK and Stat3 and expression of c-fos and c-jun proteins onhepatocarcinogenesis and their clinical significance[J].World J Gas-troenterol.2001, 7 (1) ∶33-6.
|
[4]Zhang XL, Liu JM, Yang CC, et al.Dynamic expression of extracel-lular signal-regulated kinase in rat liver tissue during hepatic fibro-genesis[J].World J Gastroenterol, 2006, 12 (39) ∶6376-81.
|
[5]Son G, Iimuro Y, Seki E, et al.Selective inactivation of NF-kap-paB in the liver using NF-kappaB decoy suppresses CCl4-inducedliver injury and fibrosis[J].Am J Physiol Gastrointest Liver Physiol, 2007, 293 (3) ∶G631-9.
|
[6]Leclercq IA, Farrell GC, Sempoux C, et al.Curcumin inhibit SNF-kappaB activation and reduces the severity of experimental steato-hepatitis in mice[J].J Hepatol, 2004, 41 (6) ∶926-34.
|
[7]陈科全, 周宇.核因子NF-B与肝纤维化的关系研究现状[J].国际消化病杂志, 2007, 27 (1) ∶9-12.
|
[8]Nanji AA, Jokelainen K, Tipoe GL, et al.Curcumin prevents alco-hol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes[J].Am J Physiol Gastrointest LiverPhysiol, 2003, 284 (2) ∶G321-7.
|
[1] | Wang HongSha, Wei Qi, Lei ManMan, Jin QingLong, Wen XiaoYu, Guo YuYing. Acute hepatitis B complicated by EB virus infection: a case report[J]. Journal of Clinical Hepatology, 2017, 33(4): 725-727. doi: 10.3969/j.issn.1001-5256.2017.04.026 |
[2] | Zhu Peng, Tang Yi, Wang YuMing. Recommendations for APASL Clinical Practice Guidelines: management of hepatitis B (updated in 2015)[J]. Journal of Clinical Hepatology, 2016, 32(3): 423-428. doi: 10.3969/j.issn.1001-5256.2016.03.004 |
[3] | Li Jun. Clinical research progress in integrated traditional Chinese and Western medicine therapy for HBV-related liver failure[J]. Journal of Clinical Hepatology, 2015, 31(1): 42-47. doi: 10.3969/j.issn.1001-5256.2015.01.010 |
[4] | Sun YuMei, Zhou YingXia, Xing HuiChun, Lin KeKe. Clock drawing test in cognitive assessment for patients with hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 413-417. doi: 10.3969/j.issn.1001-5256.2015.03.024 |
[5] | Xu Ying, Liu Yu, Sun Jian. Key points of the AASLD′s guidelines on hepatitis B diagnosis and treatment[J]. Journal of Clinical Hepatology, 2013, 29(2): 162-169. |
[6] | Yan Tao, Li Fan, Li Ke, Zhao Ping, Wang HuiFen. Analysis of mutational patterns of the pre-C/C region of with hepatitis B virus in patients with HBV-associated acute-on-chronic liver failure [J]. Journal of Clinical Hepatology, 2013, 29(2): 120-123+127. |
[7] | Jiang LiSheng, Li YongGuo, Chen Shu, Lan YingHua. Short-term and long-term efficacy of antiviral treatment of patients with HBV-associated acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2013, 29(2): 110-113. |
[8] | Cao Xiao, Cao QingBao, Zhang GuoQiang, Chang ZaiJuan, Li ShuPing, Xu WeiWei. Analysis of occult hepatitis B virus infection among blood donors in Tangshan, China[J]. Journal of Clinical Hepatology, 2013, 29(2): 117-119. |
[9] | Zhang Tao, Sun KeWei. Experience and progresses of Chinese medicine therapy for hepatitis B-associated liver failure[J]. Journal of Clinical Hepatology, 2012, 28(3): 169-171+182. |
[10] | Peng JianPing, Sun KeWei, Wu YuNan. Impact of early virological response to antiviral treatment on the outcomes of hepatitis B-associated liver failure [J]. Journal of Clinical Hepatology, 2012, 28(10): 752-755. |
[11] | Wang XiaoJing, Ning Qin. Prospect and progression on severe acute exacerbation of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2012, 28(6): 401-404+412. |
[12] | Hu XiaoLi, Zhao HongWei, Wu XiaoYan, Niu JunQi. Prevalence of hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2012, 28(6): 413-416+421. |
[13] | Deng Le, Wen ZhiLi. Review of recent research progress in correlating HBV genotypes with efficacy of antiviral treatments[J]. Journal of Clinical Hepatology, 2012, 28(6): 469-473. |
[14] | Gao Zhen, Zhang LunLi. Toll like receptors mediated innate immune responses against HBV infection[J]. Journal of Clinical Hepatology, 2011, 27(6): 667-669+673. |
[15] | Yuan JianGuo, Wang XinGuo, Cui Xia, Liu FengHua, Wang FengHua, Song JiKui, Zhao HongKui. The activation of rat hepatic stellate cells stimulated with hepatitis B virus in vitro[J]. Journal of Clinical Hepatology, 2011, 27(2): 163-165. |
[16] | Zhao YanJuan, Ye ChunYan, Song XiaoDan. The change in serum thyroid hormone levels in acute hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(2): 161-162+165. |
[17] | Gu MaoLin, Wang XingLiang, Wu TingTing. Detection of HBV-LP and relationships between HBV DNA and its level in HBV patients with different patterns of HBV Markers[J]. Journal of Clinical Hepatology, 2011, 27(8): 810-812. |
[18] | Yu Hui. Advances in epidemiology, diagnosis and treatment of hepatitis B in children[J]. Journal of Clinical Hepatology, 2011, 27(7): 687-689. |
[19] | Liu Li, Hu XiaoXuan. A report of severe hepatitis with wilson desease and hepatitis B[J]. Journal of Clinical Hepatology, 2010, 26(6): 657+66. |
[20] | Shi YanMei, Lan YingHua, Dan Lei, Zhou Jin, Li YongGuo. The relationship between of hematopoietic stem cells and hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2010, 26(4): 377-380. |